Navigation Links
Focus in Biological Technology

Nektar Therapeutics to Present at the BMO Capital Markets 9th Annual Focus on Healthcare Conference in New York City

SAN CARLOS, Calif., July 31 /PRNewswire-FirstCall/ -- Nektar Therapeutics (Nasdaq: NKTR ) is scheduled to present at the upcoming BMO Capital Markets 9th Annual Focus on Healthcare Conference at the Millennium Broadway Hotel in New York City on Wednesday, August 5, 2009 at 1:45 p.m. ...

FDA Grants First Authorization of a Commercial 2009 H1N1 Flu Test for use During Pandemic Flu Emergency to Quest Diagnostics' Focus Diagnostics Business

MADISON, N.J., July 24 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX ), the world's leading provider of diagnostic testing, information and services, today announced that the U.S. Food and Drug Administration (FDA) has granted an emergency use authorization to the...

Anadys Pharmaceuticals, Inc. Announces Strategic Restructuring to Focus Operations on Continuing the Advancement of ANA598

SAN DIEGO, June 4 /PRNewswire-FirstCall/ -- Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS ) today announced a strategic restructuring to focus its operations on the development of ANA598, in particular a proposed Phase II study in hepatitis C patients of ANA598 in combination with pegylated int...

New Stem Cell Web Site to Focus on Traumatic Brain Injury, Spinal Cord Injury and Diabetes

SAN DIEGO, May 28 /PRNewswire/ -- Entest BioMedical, Inc., a newly formed wholly-owned subsidiary of San Diego-based Bio-Matrix Scientific Group, Inc. (OTC Bulletin Board: BMSN) announced today the launch of its Web site ( http://www.EntestBio.com ) to focus on new stem cell research, includin...

Sixth Annual Healthcare Unbound Conference to Focus on Remote Monitoring, Home Telehealth & eHealth for Chronic Care Management & Wellness Promotion

ROLLING HILLS ESTATES, Calif., May 7 /PRNewswire/ -- The Sixth Annual Healthcare Unbound Conference & Exhibition, organized by The Center for Business Innovation (TCBI), will feature the coming together of consumer and healthcare technologies to facilitate participatory medicine . The Conf...

Health Strategies Group Expands Focus of Pharma Sales Force Effectiveness Service Under New Vision and Name

Strategic Selling Outlook Addresses Rapidly Changing Selling Environment and Future Needs of Physicians and Sales Representatives LAMBERTVILLE, N.J., April 16 /PRNewswire/ -- Health Strategies Group, a leading provider of market intelligence to the pharmaceutical and biotechnology industrie...

Telik Implements Reorganization to Focus Resources Toward Drug Development Pipeline

PALO ALTO, Calif., Feb. 11 /PRNewswire-FirstCall/ -- Telik, Inc. (Nasdaq: TELK ) announced today that it is implementing a reorganization to focus on its most advanced preclinical and clinical drug development programs. The reorganization will enable the company to continue the developme...

'Enrichment of Genomic Loci for Targeted Sequencing Application' Is Focus of 2009 AGBT Conference Workshop

LEXINGTON, Mass., Jan. 30 /PRNewswire/ -- Jeff Olson, Manager of Nucleic Acid Applications, of RainDance Technologies, Inc., will present " Enrichment of Genomic Loci for Targeted Sequencing Applications , " to explain application of the RainStorm micro-droplet technology on the new RDT 1000 in...

Alexza Consolidates Operations to Focus Resources on AZ-004 (Staccato(R) Loxapine) for Acute Agitation

MOUNTAIN VIEW, Calif., Jan. 29 /PRNewswire-FirstCall/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ) announced today that it has consolidated its operations, with a primary focus on the continued rapid development of AZ-004 (Staccato loxapine). The restructuring includes a workforce reduct...

Nile Therapeutics Announces Focus on CD-NP for Acute Heart Failure and Termination of 2NTX-99 Program

SAN FRANCISCO, Jan. 20 /PRNewswire-FirstCall/ -- Nile Therapeutics, Inc. (Nasdaq: NLTX ), today announced that it will focus resources on the development of its natriuretic peptide franchise, including CD-NP which is in Phase II development for acute heart failure, and CU-NP which is a pre-clini...

Patient Safety in Challenging Economic Times is Focus of NPSF Annual Congress on May 20-22

BOSTON, Jan. 13 /PRNewswire/ -- Responding to the increased risk to patient safety in an economic downturn, the National Patient Safety Foundation has announced that the 2009 NPSF Patient Safety Congress will directly address this issue through an extensive program of educational sessions desi...

'Biology in Pico-Liter Droplets' is Focus of Presentation at LabAutomation 2009

LEXINGTON, Mass., Jan. 12 /PRNewswire/ -- Darren R. Link, Ph.D., of RainDance Technologies, Inc., will present " Biology in Pico-Liter Droplets, " a discussion of the commercialization of the use of picoliter droplets in microfluidic channels for applications in the life sciences, at the LabAuto...

Nikon Instruments Perfect Focus System Wins Second Place in The Scientist's Top Innovations of 2008 Award

MELVILLE, N.Y., Dec. 15 /PRNewswire/ -- A panel of expert judges selected Nikon Instruments, Inc.'s ( www.nikoninstruments.com ) Ti-E Perfect Focus System (PFS) as second place among the top ten in The Scientist's Top Innovations of 2008 Award, which recognizes winning combinations of invention,...

GEN Reports Growing Focus on PI3-Kinase Pathway in Cancer Research

NEW ROCHELLE, N.Y., Dec. 4 /PRNewswire/ -- Researchers are taking a closer look at the phosphoinositide 3-kinase (PI3-kinase) pathway as studies continue to demonstrate that inhibiting this biological route suppresses tumor growth, reports Genetic Engineering & Biotechnology News (GEN) . The ...

WuXi PharmaTech Will Focus U.S. Operations on Laboratory Testing Services

SHANGHAI, China, Dec. 2 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX ), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, today announced it will dedicate its Philadelphia facili...

Arpida to Restructure and Focus on Key Projects

REINACH, Switzerland, November 27 /PRNewswire-FirstCall/ -- Arpida announced today that it is refocusing all projects and priorities around the key strategic asset Iclaprim. The company says this is to be seen as a consequence of the negative recommendation of the U.S. Food and Drug Administra...

Anadys Pharmaceuticals to Present at the Needham Focus on Infectious Disease Conference

SAN DIEGO, Nov. 13 /PRNewswire-FirstCall/ -- Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS ) announced today that it will present at the Needham & Company, LLC's Focus on Infectious Disease Conference on Thursday, November 20, 2008 at 10:00 a.m. EST (7:00 a.m. PST) at the Needham and Company, LL...

GlaxoSmithKline to Acquire Genelabs Technologies to Increase Focus on Novel Small Molecule Therapies for Hepatitis C

PHILADELPHIA, Oct. 29 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE: GSK) (LSE: GSK) and Genelabs Technologies, Inc. (Nasdaq: GNLB ) announced today that they have entered into a definitive agreement pursuant to which GSK will acquire Genelabs for approximately $57 million (pounds Sterling ...

Isolagen to Present at the JMP Securities Healthcare Focus Conference

EXTON, Pa., Oct. 3 /PRNewswire-FirstCall/ -- Isolagen, Inc. (Amex: ILE ) announced today that Declan Daly, Chief Executive Officer, will present at the JMP Securities Healthcare Focus Conference on Monday, October 6, 2008 at 3:30 p.m. (EST) at Le Parker Meridien hotel in New York, New York. ...

ARCA biopharma to Present at JMP Securities Healthcare Focus Conference

Webcast Presentation Scheduled for Monday, October 6, 2008 at 3:00 p.m. EDT BROOMFIELD, Colo., Oct. 2 /PRNewswire/ -- ARCA biopharma, Inc., a biopharmaceutical company developing genetically-targeted therapies for heart failure and other cardiovascular diseases, today announced that Richard Brew...

Horizon Therapeutics to Present at JMP Securities Healthcare Focus Conference

SKOKIE, Ill., Oct. 1 /PRNewswire/ -- Horizon Therapeutics, Inc., a privately held biopharmaceutical company, announced today that Timothy P. Walbert, president and chief executive officer, will present a corporate overview at the JMP Securities Healthcare Focus Conference in New York on Tuesda...

BioCryst to Present at the JMP Healthcare Focus Conference

BIRMINGHAM, Ala., Oct. 1 /PRNewswire-FirstCall/ -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX ) today announced that Jon P. Stonehouse, Chief Executive Officer and President of BioCryst, will present a corporate update at the JMP Healthcare Focus Conference in New York on Monday, October 6,...

Pharmasset to Present at the JMP Securities Healthcare Focus Conference on Monday, October 6th

PRINCETON, N.J., Oct. 1 /PRNewswire-FirstCall/ -- Pharmasset, Inc. (Nasdaq: VRUS ) management will present at the Third Annual JMP Securities Healthcare Focus Conference being held from October 6-7, 2008 at the Le Parker Meridien in New York City. Schaefer Price, Pharmasset's Chief Executive ...

NxStage Medical to Present at JMP Securities Healthcare Focus Conference

LAWRENCE, Mass., Sept. 30 /PRNewswire-FirstCall/ -- NxStage Medical, Inc. (Nasdaq: NXTM ), a leading manufacturer of innovative dialysis products, today announced that Jeffrey H. Burbank, Chief Executive Officer, and Robert S. Brown, Chief Financial Officer, will be presenting at the JMP Secu...

Genomic Health to Present at JMP Securities Healthcare Focus Conference

REDWOOD CITY, Calif., Sept. 30 /PRNewswire-FirstCall/ -- Genomic Health, Inc. (Nasdaq: GHDX ) today announced that Kim Popovits, Genomic Health's President and Chief Operating Officer, will present at the JMP Securities Healthcare Focus Conference in New York on Tuesday, October 7, 2008 at 10...

Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at the JMP Securities Third Annual Healthcare Focus Conference

SAN DIEGO, Sept. 29 /PRNewswire-FirstCall/ -- Cadence Pharmaceuticals, Inc. (Nasdaq: CADX ), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting, announced today that the company's Presi...

Poniard Pharmaceuticals to Present at the JMP Securities Healthcare Focus Conference

SOUTH SAN FRANCISCO, Calif., Sept. 29 /PRNewswire-FirstCall/ -- Poniard Pharmaceuticals, Inc. (Nasdaq: PARD ), a biopharmaceutical company focused on oncology, today announced that Jerry McMahon, Ph.D., chairman and CEO, will present at the JMP Securities Healthcare Focus Conference on Monday...

Nomad Bioscience: New Plant Biotechnology Company Founded to Focus on Biomaterials and Biopharmaceuticals

MUNICH, Germany, Sept. 29 /PRNewswire/ -- NOMAD Bioscience GmbH, Munich, Germany (NOMAD) is a private biotechnology company developing plant-made biomaterials and biopharmaceuticals that address critical unmet needs. NOMAD is developing a series of high-value products such as nanopatterned mat...

2008 National Ergonomics Conference Schedule Announced, Features Four New Tracks of Programming and Focus on Corporate Sustainability and Productivity; Most Product Debuts in Expo's 14-Year History

NEW YORK, Sept. 17 /PRNewswire/ -- The 14th Annual National Ergonomics Conference and Exposition (NECE) at Caesars Palace, Las Vegas, Dec. 2-5, will feature a record number of conference sessions, and mark the debut of four new tracks of conference programming geared toward workplace design an...

Ardea Biosciences to Present at the UBS Global Life Sciences Conference and the Third Annual JMP Securities Healthcare Focus Conference

SAN DIEGO, Sept. 17 /PRNewswire-FirstCall/ -- Ardea Biosciences, Inc. (Nasdaq: RDEA ) announced today that Barry D. Quart, PharmD, President and CEO of Ardea Biosciences, will present at two upcoming investor conferences. UBS Global Life Sciences Conference Date: Wednesday, September ...

Atrial Fibrillation Month - StopAfib.org Announces September Focus on Life-Threatening Irregular Heartbeat

DALLAS, Sept. 2 /PRNewswire/ -- StopAfib.org, at http://www.StopAfib.org, announces that September is Atrial Fibrillation Month to raise awareness of this life-threatening irregular heartbeat, commonly called afib or AF. Once considered benign, this common cardiac arrhythmia can often lead...

Pipeline for Breast Cancer Therapies is Focus of New MedPredict Report

SCOTTSDALE, Ariz., Aug. 27 /PRNewswire/ -- MedPredict has published a new report in its oncology series entitled "Thought Leader Insight & Analysis: Breast Cancer," designed to provide critical strategic insight for pharma and biotech companies with a stake in the market for diagnostics and tr...

Leading AIDS Experts Urge Greater Focus on Behavior-Change Programs to Prevent HIV

Report: Hundreds of Studies Show that Programs to Curb Unsafe Sex and Drug Use are Highly Effective, but Often Overlooked in Global AIDS Response MEXICO CITY, Aug. 5 /PRNewswire/ -- In a new report released today, an international panel of AIDS experts calls on global leaders to aggressively...

Bionovo to Present at BMO Capital Markets 2008 Focus on Healthcare Conference

EMERYVILLE, Calif., Aug. 4 /PRNewswire-FirstCall/ -- Bionovo, Inc. (Nasdaq: BNVI ), a pharmaceutical company focused on the discovery and development of safe and effective drugs in the areas of women's health and cancer, announced today that Tom Chesterman, SVP and CFO of Bionovo, will be pre...

Medivation Announces Presentation at the BMO Capital Markets 2008 Focus on Healthcare Conference on August 5

SAN FRANCISCO, Aug. 1 /PRNewswire-FirstCall/ -- Medivation, Inc. (Nasdaq: MDVN ) today announced that David Hung, M.D., president and chief executive officer, will present at the BMO Capital Markets 2008 Focus on Healthcare Conference on Tuesday, August 5, at 11:15 a.m. Eastern Time at the Mi...

Sangamo BioSciences to Present at the BMO Capital Markets Focus on Healthcare Conference

RICHMOND, Calif., July 29 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO ) announced today that Edward Lanphier, Sangamo's president and CEO, will provide an update on the progress of Sangamo's ZFP Therapeutic development programs and an overview of the company's business s...

VNUS Medical Technologies to Present at BMO Capital Markets 2008 Focus on Healthcare Conference

SAN JOSE, Calif., July 28 /PRNewswire-FirstCall/ -- VNUS(R) Medical Technologies, Inc. (Nasdaq: VNUS ), a leading provider of medical devices for the minimally invasive treatment of venous reflux disease, today announced its plans to present at the BMO Capital Markets 2008 Focus on Healthcare...

Joint nanotechnology forum to focus on electronics, photonics, renewable energy

Applications of nanotechnology to electronics, photonics and renewable energy will be the focus of a joint forum to be held from August 10 to 14, 2009 at McMaster University in Hamilton, Ontario, Canada. An innovation workshop will also be presented in conjunction with the event. The 4th Nano ...

Fifth Annual Healthcare Unbound Conference to Focus on Remote Monitoring, Home Telehealth & eHealth for Disease Management & Wellness Promotion

ROLLING HILLS ESTATES, Calif., June 19 /PRNewswire-USNewswire/ -- The Fifth Annual Healthcare Unbound Conference and Exhibition, hosted by The Center for Business Innovation (TCBI), will feature the coming together of consumer and healthcare technologies to promote wellness and to help manage d...

South Palm Orthospine Institute Now Open: World Renowned Orthopedic Specialist and Author, Stewart G. Eidelson, Announced the New Practice with a Focus on Spine and Spinal Stenosis

Founder of SpineUniverse.com and South Florida Spinal Stenosis Foundation, the internationally acclaimed surgeon presents the new state-of-the-art research, technology and treatment centers in Delray, Boynton Beach & Boca Raton. BOYNTON BEACH, Fla., June 6 /PR...
Other Tags
(Date:12/5/2014)... Dec. 4, 2014  Tute Genomics, a leader in ... in Series A1 funding led by UK-based Eurovestech. Peak ... in the investment round. "We are at ... adopts next-generation sequencing and seeks new approaches for the ... Robison , MD MBA, and CEO of Tute Genomics. ...
(Date:12/3/2014)... Dec. 2, 2014 As part of our ... Technologies is pleased to announce the release of a ... to collect the workforce data that they need. ... been left by existing readers. Many such devices have ... and modern technology. Older models force users to navigate ...
(Date:11/21/2014)... VIEW, Calif. , Nov. 20, 2014 ... higher driver efficiency are piloting the North American and ... number of accidents growing, gesture recognition systems that are ... make a mark in the industry. ... the Automotive Gesture Recognition Market in Europe ...
Breaking Biology News(10 mins):Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 2Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 3Inception Technologies to Release New Biometric Reader 2Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 2Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 3Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 4
(Date:12/25/2014)... Recently, BellasDress has launched its ... dresses. BellasDress has chosen their best-selling lace wedding dresses, ... the holiday season. , Now, BellasDress.com features popular ... here at discount prices. The business hopes everyone can ... , “All our elegant products are made ...
(Date:12/25/2014)... 25, 2014 Helen Harris’ RP (Retinitis ... Hills, California after an 8 year battle with breast ... Eve evening in her home in Woodland Hills California ... cancer. , As the founder and ... she pioneered and championed many of today's greatest breakthroughs ...
(Date:12/25/2014)... December 25, 2014 Recently, LunaDress.co.uk has updated its ... and related accessories. Now, all of the models at LunaDress.co.uk come ... a groom lifts the wedding veil can turn out to be ... charm. A wedding veil can always bring surprise to a wedding. ... on how to choose veils for a big day . ...
(Date:12/25/2014)... 25, 2014 (HealthDay News) -- The risk of burns ... so you need to be extra cautious, an expert ... see a significant increase in patients coming in with ... Suffolk County Volunteer Firefighters Burn Center of Stony Brook ... be full of joy, but if not careful, could ...
(Date:12/25/2014)... News) -- Among early stage breast cancer patients who ... one percent will eventually develop leukemia as a result ... finding comes from a review of more than 20,000 ... it suggests that the risk for developing treatment-related leukemia, ... thought. "The frequency of bone marrow cancers such ...
Breaking Medicine News(10 mins):Health News:BellasDress.com’s Christmas Sale: Trendy Wedding Dresses With Big Discounts 2Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 2Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 3Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 4Health News:LunaDress Provides Professional Tips On Shopping Wedding And Prom Dresses 2Health News:Don't Let Burns Mar Your Holidays 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 3
Other Contents